Updated September 2026Billed every other monthLevers Health review
The advertised monthly figure is half of a charge that lands every two months, and the catalog card shows the real one.
The verdict
Levers Health markets compounded semaglutide at $123 a month, read August 2026, and bills $246 every other month. Its own catalog card reads From $246, which is the figure a buyer meets.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Rises with dose
- From
- $123/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Levers Health sells both molecules by injection, with the semaglutide line shipped and billed on a two-month cycle rather than monthly.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages describe products and cycles rather than clinicians. The intake is not documented.
Halving a two-month charge to advertise a monthly figure is not wrong arithmetic, and it is not what a buyer is charged either. The seller publishes both numbers, which is more than some do, and the one on the catalog card is the one that lands.
What happens when the dose goes up?
The cost rises with the dose here, and the advertised tirzepatide figure is a low-dose tier at $296 rather than the $396 any-dose plan. So the cheaper number describes a narrower product, and the storefront advertises the narrower one.
What the price includes
$246 every other month is $1,476 a year, which does work out at $123 a calendar month — the arithmetic holds. What changes is cash flow and commitment: a buyer pays $246 at a time and cannot stop after a single month. On tirzepatide, the $296 low-dose tier sits $100 below the any-dose plan, so escalating past the tier costs more than the card implies.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Both the cycle and the charge are published
- Strength: The catalog card shows the real figure
- Strength: The low-dose tier is labeled as one
- Limitation: Billed $246 every other month
- Limitation: A single month cannot be bought
- Limitation: The advertised tirzepatide is a low-dose tier
- Limitation: The any-dose plan costs $100 more
What the evidence says about this kind of treatment
The assessment above is about Levers Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader comfortable paying in two-month blocks who wants a low-dose tier.
- Wrong for
- A reader who wants to pay monthly, or who needs a full dose.
How Levers Health compares
| Seller | Who it suits | Go |
|---|---|---|
 Live Vital | Readers who work from the protocol total rather than the monthly figure beside it | See Live Vital → |
| LeanDose | Readers who will get the month-two rate in writing before the first charge | See LeanDose → |
| LevelsRx | Readers who want the oral option and will ask what the ladder costs | See LevelsRx → |
More GLP-1 telehealth sellers reviews: Rex MDSesame CareSomira HealthSprout HealthStackMDSumbare Wellness
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Am I charged $123 a month?
- No. The charge is $246 every other month. The annual arithmetic matches $123, but a buyer pays in two-month blocks.
- Is $296 the full tirzepatide price?
- It is the low-dose tier, which is what the storefront advertises. The any-dose plan is $396.
- Can I buy one month?
- The cycle is two months, so a single month is not offered on the semaglutide line.
- Is Levers Health expensive compared with other GLP-1 telehealth sellers?
- Levers Health publishes a starting figure of $123/mo. Across the 137 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $184, which puts Levers Health below the median, toward the cheaper end. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.